(1Z,5S,8aS,12aS)-5-ethenyl-5,8a,12,12-tetramethyl-6,7,9,10,11,12a-hexahydro-4-benzoxecine-3,8-dione

Details

Top
Internal ID 2ffc096d-af6d-4a92-971e-7475431f742a
Taxonomy Organoheterocyclic compounds > Oxocins
IUPAC Name (1Z,5S,8aS,12aS)-5-ethenyl-5,8a,12,12-tetramethyl-6,7,9,10,11,12a-hexahydro-4-benzoxecine-3,8-dione
SMILES (Canonical) CC1(CCCC2(C1C=CC(=O)OC(CCC2=O)(C)C=C)C)C
SMILES (Isomeric) C[C@]1(CCC(=O)[C@]2(CCCC([C@@H]2/C=C\C(=O)O1)(C)C)C)C=C
InChI InChI=1S/C19H28O3/c1-6-18(4)13-10-15(20)19(5)12-7-11-17(2,3)14(19)8-9-16(21)22-18/h6,8-9,14H,1,7,10-13H2,2-5H3/b9-8-/t14-,18+,19-/m0/s1
InChI Key WJZRVHVTAIZASV-RSDVVFHSSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C19H28O3
Molecular Weight 304.40 g/mol
Exact Mass 304.20384475 g/mol
Topological Polar Surface Area (TPSA) 43.40 Ų
XlogP 4.20
Atomic LogP (AlogP) 4.23
H-Bond Acceptor 3
H-Bond Donor 0
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1Z,5S,8aS,12aS)-5-ethenyl-5,8a,12,12-tetramethyl-6,7,9,10,11,12a-hexahydro-4-benzoxecine-3,8-dione

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9915 99.15%
Caco-2 + 0.8282 82.82%
Blood Brain Barrier + 0.5750 57.50%
Human oral bioavailability + 0.5143 51.43%
Subcellular localzation Mitochondria 0.6482 64.82%
OATP2B1 inhibitior - 0.8570 85.70%
OATP1B1 inhibitior + 0.8771 87.71%
OATP1B3 inhibitior + 0.9262 92.62%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.5500 55.00%
BSEP inhibitior - 0.5000 50.00%
P-glycoprotein inhibitior - 0.7857 78.57%
P-glycoprotein substrate - 0.9202 92.02%
CYP3A4 substrate + 0.5818 58.18%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.9097 90.97%
CYP3A4 inhibition - 0.6713 67.13%
CYP2C9 inhibition - 0.9125 91.25%
CYP2C19 inhibition - 0.7271 72.71%
CYP2D6 inhibition - 0.9613 96.13%
CYP1A2 inhibition - 0.7339 73.39%
CYP2C8 inhibition - 0.7108 71.08%
CYP inhibitory promiscuity - 0.9796 97.96%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8800 88.00%
Carcinogenicity (trinary) Non-required 0.6588 65.88%
Eye corrosion - 0.9598 95.98%
Eye irritation - 0.8627 86.27%
Skin irritation + 0.5635 56.35%
Skin corrosion - 0.8873 88.73%
Ames mutagenesis - 0.7354 73.54%
Human Ether-a-go-go-Related Gene inhibition - 0.4508 45.08%
Micronuclear - 0.8700 87.00%
Hepatotoxicity + 0.5844 58.44%
skin sensitisation + 0.5946 59.46%
Respiratory toxicity - 0.5111 51.11%
Reproductive toxicity - 0.5719 57.19%
Mitochondrial toxicity - 0.5125 51.25%
Nephrotoxicity + 0.5572 55.72%
Acute Oral Toxicity (c) III 0.7429 74.29%
Estrogen receptor binding - 0.5312 53.12%
Androgen receptor binding - 0.6392 63.92%
Thyroid receptor binding + 0.5397 53.97%
Glucocorticoid receptor binding + 0.6857 68.57%
Aromatase binding - 0.6043 60.43%
PPAR gamma - 0.5907 59.07%
Honey bee toxicity - 0.7664 76.64%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity + 0.6300 63.00%
Fish aquatic toxicity + 0.9943 99.43%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.45% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.95% 95.56%
CHEMBL253 P34972 Cannabinoid CB2 receptor 91.59% 97.25%
CHEMBL2581 P07339 Cathepsin D 86.57% 98.95%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.69% 100.00%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 83.70% 99.23%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 82.44% 94.45%
CHEMBL1293249 Q13887 Kruppel-like factor 5 80.93% 86.33%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.60% 97.09%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Haplopappus parvifolius

Cross-Links

Top
PubChem 101619536
LOTUS LTS0267765
wikiData Q105307150